UK Dose finding studies define the dose in terms of the quantity of treatment given to a patient. In order to undertake a successful drug development programme the standard dose has to be identified early on. This is the dose that will be used in all further Phase III confirmatory trials.
Many statisticians feel that dose selection is often very poorly done.
This briefing will identify methods to achieve the optimal dose of a drug and highlight the problems and the practical solutions. Full documentation will be provided to all attendees and adequate time made available for questions.